AlgiPharma awarded 4 year grant from the Norwegian Research Council’s NANO2021 programme
AlgiPharma has been awarded up to NOK 10 million from the Norwegian Research Council for the project “Novel alginate oligomer products for enhanced delivery across mucosal barriers (Mucos-ALG)”.